Kerecis Expands Surgical and Trauma Wound Care Solutions
Kerecis, a pioneering company in the medical field, is revolutionizing the treatment of surgical and trauma wounds with its latest product, SurgiClose® Silicone. By utilizing sustainably sourced fish skin and incorporating advanced materials, the company aims to enhance wound management practices across medical facilities.
Introducing SurgiClose® Silicone
The newly launched SurgiClose® Silicone merges a fish-skin graft with a silicone backing. This innovative combination is designed to streamline the treatment process for various types of wounds. With two distinct variations available, practitioners can choose between SurgiClose® Silicone Adhesive with overlapping borders or SurgiClose® Silicone Standard with non-overlapping borders, offering flexibility in application.
Simplifying the Surgical Process
Fertram Sigurjonsson, Kerecis Founder and CEO, explains that traditional wound treatment often involves multiple supporting products, such as sutures and surgical tapes. By integrating a silicone-contact layer with their fish-skin graft, the new product simplifies the surgical workflow and reduces overall costs without compromising care quality. This not only benefits healthcare providers but also enhances patient experiences during recovery.
About Kerecis and Its Commitment to Innovation
Kerecis, established by Fertram Sigurjonsson, is dedicated to developing groundbreaking fish skin and fatty acid products. The company’s offerings cater to cellular therapy, tissue regeneration, and protection. Their unique products boast remarkable properties, allowing them to mimic human tissue closely.
The gentle processing of Kerecis fish skin retains its natural structure and strength. Clinical studies consistently demonstrate that Kerecis products expedite healing processes compared to conventional treatments. Notably, Kerecis stands as the only global manufacturer of medical devices utilizing intact fish skin, rapidly gaining traction in the U.S. biologics skin market. Their product lineup includes renowned solutions such as SurgiBind®/SurgiClose®, GraftGuide®, MariGen®, and Shield™, further establishing Kerecis as a leader in the field.
Environmental Responsibility and Sustainable Practices
Aligned with the UN Sustainable Development Goals, Kerecis is committed to sustainable practices. The company procures fish from Iceland, ensuring responsible sourcing and utilizing renewable energy processes. They recognize their responsibility in protecting the environment while delivering innovative healthcare solutions.
A Bright Future for Kerecis
As Kerecis continues to expand its range of products, it remains focused on advancing wound care techniques that align with modern medical needs. The introduction of SurgiClose® Silicone exemplifies their commitment to quality, efficiency, and sustainability in healthcare.
Frequently Asked Questions
What is SurgiClose® Silicone?
SurgiClose® Silicone is an innovative wound treatment product that combines fish-skin grafts with a silicone backing, designed for efficient management of surgical and trauma wounds.
How does Kerecis ensure sustainability?
Kerecis utilizes sustainably sourced Icelandic fish and processes it using renewable energy, aligning its practices with the UN Sustainable Development Goals.
What are the benefits of using fish skin in wound care?
Fish skin closely mimics human tissue, promoting faster healing and minimizing disease-transfer risks, making it an excellent option for wound treatment.
Are there different variations of SurgiClose® Silicone?
Yes, it is available in two versions: SurgiClose® Silicone Adhesive with overlapping borders and SurgiClose® Silicone Standard with non-overlapping borders.
Who is the founder of Kerecis?
Kerecis was founded by Fertram Sigurjonsson, who has played a pivotal role in developing its innovative product range.
